PLG0206
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PLG0206, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty [Phase 2, Phase 3]